- Research Article
- Published:
Thy28 partially prevents apoptosis induction following engagement of membrane immunoglobulin in WEHI-231 B lymphoma cells
Cellular & Molecular Biology Letters volume 17, pages 36–48 (2012)
Abstract
Thy28 protein is conserved among plants, bacteria, and mammalian cells. Nuclear Thy28 protein is substantially expressed in testis, liver, and immune cells such as lymphocytes. Lymphocyte apoptosis plays a crucial role in homeostasis and formation of a diverse lymphocyte repertoire. In this study, we examined whether Thy28 affects induction of apoptosis in WEHI-231 B lymphoma cells following engagement of membrane immunoglobulin (mIg). Once they were established, the Thy28-overexpressing WEHI-231 cells showed similar expression levels of IgM and class I major histocompatibility complex (MHC) molecule compared with controls. The Thy28-overexpressing cells were considerably resistant to loss of mitochondrial membrane potential (ΔΨm), caspase-3 activation, and increase in annexin-positive cells upon mIg engagement. These changes were concomitant with an increase in G1 phase associated with upregulation of p27Kip1. The anti-IgM-induced sustained activation of c-Jun N-terminal kinase (JNK), which was associated with late-phase hydrogen peroxide (H2O2) production, was partially reduced in the Thy28-expressing cells relative to controls. Taken together, the data suggest that in WEHI-231 B lymphoma cells, Thy28 regulates mIg-mediated apoptotic events through the JNK-H2O2 activation pathway, concomitant with an accumulation of cells in G1 phase associated with upregulation of p27Kip1 in WEHI-231 B lymphoma cells.
Abbreviations
- Abs:
-
antibodies
- FSC:
-
forward scatter
- H2O2 :
-
hydrogen peroxide
- JNK:
-
prolonged c-Jun N-terminal kinase
- MAPKs:
-
mitogen-activated protein kinases
- mIg:
-
membrane immunoglobulin
- SSC:
-
side scatter
References
Miyaji, H., Yoshimoto, T., Asakura, H., Komachi, A., Takasaki, M. and Mizuguchi, J. Molecular cloning and characterization of the mouse thymocyte protein gene. Gene 297 (2002) 189–196.
Compton, M.M., Thomson, J. M. and Icard, A.H. The analysis of cThy28 expression in avian lymphocytes. Apoptosis 6 (2001) 299–314.
Jiang, X., Toyota, H., Takada, E., Yoshimoto, T., Kitamura, T., Yamada, J. and Mizuguchi, J. Modulation of mThy28 nuclear protein expression during thymocyte development. Tissue Cell 35 (2003) 471–478.
Opferman, J.T. and Korsmeyer, S.J. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4 (2003) 410–415.
Goodnow, C.C., Sprent, J., Fazekas de St Groth, B. and Vinuesa, C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435 (2005) 590–597.
Scott, D.W., Livnat, D., Pennell, C.A. and Keng, P. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J. Exp. Med. 164 (1986) 156–164.
Takada, E., Toyota, H., Suzuki, J. and Mizuguchi, J. Prevention of anti-IgMinduced apoptosis accompanying G1 arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1. J. Immunol. 166 (2001) 1641–1649.
DeFranco, A.L., Gold, M.R. and Jakway, J.P. B-lymphocyte signal transduction in response to anti-immunoglobulin and bacterial lipopolysaccharide. Immunol. Rev. 95 (1987) 161–176.
An, S. and Knox, K.A. Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 386 (1996) 115–122.
Furuhata, M., Takada, E., Noguchi, T., Ichijo, H. and Mizuguchi, J. Apoptosis signal-rgulating kinase (ASK)-1 mediates apoptosis through activation of JNK1 following engagement of membrane immunoglobulin. Exp. Cell Res. 315 (2009) 3467–3476.
Reed, J.C. Bcl-2 family proteins. Oncogene 17 (1998) 3225–3236.
Takada, E., Hata, K. and Mizuguchi, J. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31. Exp. Cell Res. 312 (2006) 3728–3738.
Herold, M.J., Kuss, A.W., Kraus, C. and Berberich, I. Mitochondriadependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells. J. Immunol. 168 (2002) 3902–3909.
Weston, C.R. and Davis, R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19 (2007) 142–149.
Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A. and Davis, R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288 (2000) 870–874.
Takada, E., Hata, K. and Mizuguchi, J. c-Jun NH(2)-terminal kinase (JNK)-dependent nuclear translocation of apoptosis-inducing factor (AIF) following engagement of membrane immunoglobulin on WEHI-231 B lymphoma cells. J. Cell Biochem. 104 (2008) 1927–1936.
Saelens, X., Festjens, N., Vande Walle, L., van Gurp, M., van Loo, G. and Vandenabeele, P. Toxic proteins released from mitochondria in cell death. Oncogene 23 (2004) 2861–2874.
Susin, S.A., Zamzami, N. and Kroemer, G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1366 (1998) 151–165.
van Eijk, M. and de Groot, C. Germinal center B cell apoptosis requires both caspase and cathepsin activity. J. Immunol. 163 (1999) 2478–2482.
Jiang, X., Toyota, H., Yoshimoto, T., Takada, E., Asakura, H. and Mizuguchi, J. Anti-IgM-induced down-regulation of nuclear Thy28 protein expression in Ramos B cells. Apoptosis 8 (2003) 509–519.
Takeda, K., Hayakawa, Y., Smyth, M.J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H. and Okumura, K. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7 (2001) 94–100.
Toyota, H., Yanase, N., Yoshimoto, T., Moriyama, M., Sudo, T. and Mizuguchi, J. Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett. 189 (2003) 221–230.
Carey, G.B. and Scott, D.W. Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas. J. Immunol. 166 (2001) 1618–1626.
Donjerkovic, D. and Scott, D.W. Activation-induced cell death in B lymphocytes. Cell Res. 10 (2000) 179–192.
Richards, J.D., Dave, S.H., Chou, C.H., Mamchak, A.A. and DeFranco, A.L. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166 (2001) 3855–3864.
Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science k270 (1995) 1326–1331.
Gross, A., McDonnell, J.M. and Korsmeyer, S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899–1911.
Winter-Vann, A.M. and Johnson, G.L. Integrated activation of MAP3Ks balances cell fate in response to stress. J. Cell Biochem. 102 (2007) 848–858.
Hildeman, D., Jorgensen, T., Kappler, J. and Marrack, P. Apoptosis and the homeostatic control of immune responses. Curr. Opin. Immunol. 19 (2007) 516–521.
Bucan, V., Reimers, K., Choi, C.Y., Eddy, M.T. and Vogt, P.M. The antiapoptotic protein lifeguard is expressed in breast cancer cells and tissues. Cell. Mol. Biol. Lett. 15 (2010) 296–310.
Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J.P., Jochum, W., Wagner, E.F. and Karin, M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9 (1999) 116–125.
Ruiz-Vela, A., Gonzalez de Buitrago, G. and Martinez, A.C. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 18 (1999) 4988–4998.
Bras, A., Ruiz-Vela, A., Gonzalez de Buitrago, G. and Martinez, A.C. Caspase activation by BCR cross-linking in immature B cells: differential effects on growth arrest and apoptosis. FASEB J. 13 (1999) 931–944.
Chang, L. and Karin, M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37–40.
Chi, H., Barry, S.P., Roth, R.J., Wu, J.J., Jones, E.A., Bennett, A.M. and Flavell, R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U S A 103 (2006) 2274–2279.
Hayakawa, T., Matsuzawa, A., Noguchi, T., Takeda, K. and Ichijo, H. The ASK1-MAP kinase pathways in immune and stress responses. Microbes Infect. 8 (2006) 1098–1107.
Clarke, P.R. and Allan, L.A. Cell-cycle control in the face of damage-a matter of life or death. Trends Cell Biol. 19 (2009) 89–98.
Senderowicz, A.M. Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr. Opin. Cell Biol. 16 (2004) 670–678.
Woo, M., Hakem, R., Furlonger, C., Hakem, A., Duncan, G.S., Sasaki, T., Bouchard, D., Lu, L., Wu, G.E., Paige, C.J. and Mak, T.W. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat. Immunol. 4 (2003) 1016–1022.
Beisner, D.R., Ch’en, I.L., Kolla, R.V., Hoffmann, A. and Hedrick, S.M. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J. Immunol. 175 (2005) 3469–3473.
Zinkel, S., Gross, A. and Yang, E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 13 (2006) 1351–1359.
Hublarova, P., Greplova, K., Holcakova, J., Vojtesek, B. and Hrstka, R. Switching p53-dependent growth arrest to apoptosis via the inhibition of DNA damage-activated kinases. Cell. Mol. Biol. Lett. 15 (2010) 473–484.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toyota, H., Jiang, XZ., Asakura, H. et al. Thy28 partially prevents apoptosis induction following engagement of membrane immunoglobulin in WEHI-231 B lymphoma cells. Cell Mol Biol Lett 17, 36–48 (2012). https://doi.org/10.2478/s11658-011-0034-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11658-011-0034-8